Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2015 | Hua Medicine | $25.0M Series B | Ally Bridge Group | ARCH Venture Partners, Flagship Ventures, F-Prime Capital Partners, Meritech Capital Partners, Venrock, Fidelity Management & Research Company, SAIL Venture Partners, TF Capital, WuXi Healthcare Ventures |
| Jan 1, 2015 | Innovent Biologics | $120.0M Series C | Legend Capital | Creacion Ventures, Fidelity Growth Partners Asia, F-Prime Capital, Lilly Asia Ventures, Temasek |